Use of zebrafish to study the pathogenesis and evolution of Shigella species

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:1 publications

Grant number: 2397306

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2020
    2024
  • Known Financial Commitments (USD)

    $0
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    London Sch of Hygiene & Tropic. Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Shigella is an intracellular pathogen and dominant cause of dysentery globally. Four species are currently recognized: Shigella flexneri, Shigella sonnei, Shigella dysenteriae and Shigella boydii. Although the global phylogeography and evolutionary history of Shigella species is starting to emerge, the underlying determinants are poorly understood. Zebrafish are a wellestablished model system to study host-pathogen interactions in vivo. The Mostowy lab has recently shown zebrafish are valuable to model Shigella infection in humans. This project will use Shigella-zebrafish infection to comparatively investigate the pathogenesis of 4 Shigella species, and study evolutionary phenomena indicated by recent genomics studies from the Holt lab.

Publicationslinked via Europe PMC

P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against <i>Shigella flexneri</i>.